All In Biotech

Drug Trial Radar · NCT06672055

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

A Phase 2b, Double-Blind, Multi-Center, Randomized, Comparator-Controlled Trial to Determine the Relative Efficacy, Safety, and Immunogenicity of the Investigational Oral SARS-CoV-2 Vaccine Tablet Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 5,485 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

5,485

Planned (sponsor's estimate)

Start

Oct 8, 2024

Primary completion

May 2027

Study completion May 2027

Sponsor

Lead sponsor
VaxartIndustry
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority
First posted
Nov 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19). In order to represent a more recently circulating SARS-CoV-2 variant, the main study endpoints will now evaluate the VXA-CoV2-3.3 (KP.2 strain) vaccine, and not the VXA-CoV2-3.1 (XBB.1.5 strain) vaccine.

Conditions

  • SARS-CoV2
  • COVID-19

Interventions

  • VXA-CoV2-3.1Biological

    Tablets for oral use.

  • COMIRNATY®Biological

    Intramuscular (IM) injection.

  • VXA-CoV2-3.3Biological

    Tablets for oral use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. KP.2 Cohorts: Percentage of Participants with First Occurrence of Symptomatic Polymerase Chain Reaction (PCR)-Positive COVID-19 at 14 Days Post-vaccinationTime frame: Up to approximately Day 14
  2. KP.2 Cohorts: Percentage of Participants with First Occurrence of Symptomatic PCR-Positive COVID-19 at 12 Months Post-vaccinationTime frame: Up to approximately 12 months
  3. XBB Sentinel Cohorts: Percentage of Participants who Experience any Solicited Local Reactogenicity Through 7 Days Post-vaccinationTime frame: Up to approximately Day 7
  4. XBB Sentinel Cohorts: Percentage of Participants who Experience any Solicited Systemic Reactogenicity Through 7 Days Post-vaccinationTime frame: Up to approximately Day 7
  5. XBB Sentinel Cohorts: Percentage of Participants who Experience Unsolicited Adverse Events (AEs) Through 30 Days Post-vaccinationTime frame: Up to approximately Day 30
  6. XBB Sentinel Cohorts: Percentage of Participants who Experience Treatment-emergent Adverse Events (TEAEs) Through 12 Months Post-vaccinationTime frame: Up to approximately 12 months
  7. XBB Sentinel Cohorts: Percentage of Participants With any Clinically Significant Abnormal Safety Laboratory Results Within 7 Days Pots-vaccinationTime frame: Up to approximately Day 7

Locations

145 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • Core Clinical Trials - Central Alabama Research LLC

    Birmingham, Alabama

  • Coastal Clinical Research

    Mobile, Alabama

  • Avacare - Lenzmeier Family Medicine

    Glendale, Arizona

  • Desert Clinical Research

    Mesa, Arizona

  • Velocity Clinical Research - MedPharmics - Phoenix

    Phoenix, Arizona

  • Foothills Research Center

    Phoenix, Arizona

  • Avacare (CCT) - Fiel Family & Sports Medicine

    Tempe, Arizona

  • Baptist Health Center for Clinical Research - Little Rock

    Little Rock, Arkansas

  • Elligo Health Research (BTC/ClinEdge) - Core Healthcare Group

    Cerritos, California

  • Velocity Clinical Research - Chula Vista (eStudySite - Chula Vista)

    Chula Vista, California

  • Avacare - Benchmark Research - SOCAL-Colton

    Colton, California

  • Altasciences Los Angeles (Formerly WCCT Global)

    Cypress, California

  • Ark Clinical Research - Fountain Valley, CA

    Fountain Valley, California

  • Velocity Clinical Research - San Diego (eStudySite - La Mesa)

    La Mesa, California

  • Ark Clinical Research - Long Beach, CA

    Long Beach, California

  • Velocity Clinical Research (National Research Institute) - Panorama City

    Los Angeles, California

  • Northern California Research

    Sacramento, California

  • Avacare - Benchmark Research - Sacramento

    Sacramento, California

  • Velocity Clinical Research - Gardena

    Santa Ana, California

  • Elite Research Network (ERN) - Legacy Clinical Trials

    Colorado Springs, Colorado

  • Tekton Research - Fort Collins

    Fort Collins, Colorado

  • Avacare - Critical Care, Pulmonary and Sleep Associates

    Lakewood, Colorado

  • Tekton Research - Colorado - Longmont

    Longmont, Colorado

  • Paradigm Clinical Research - Wheat Ridge

    Wheat Ridge, Colorado

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • Chase Medical Research

    Waterbury, Connecticut

  • Velocity Clinical Research - Washington DC

    Washington D.C., District of Columbia

  • AMR - Miami (Clinical Research of South Florida)

    Coral Gables, Florida

  • Universal Axon Clinical Research

    Doral, Florida

  • Velocity Clinical Research - New Smyrna Beach

    Edgewater, Florida

  • Fleming Island Center For Clinical Research

    Fleming Island, Florida

  • AMR - Fort Myers - Clinical Physiology Associates

    Fort Myers, Florida

  • Velocity Clinical Research - Hallandale Beach (MD Clinical)

    Hallandale, Florida

  • ENCORE - Nature Coast Clinical Research Inverness

    Inverness, Florida

  • ENCORE - Westside Center for Clinical Research

    Jacksonville, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Headlands Research - JEM Research - Lake Worth

    Lake Worth, Florida

  • Accel Research Sites - Lakeland

    Lakeland, Florida

  • Accel Research Sites (ARS) - St. Petersburg - Largo

    Largo, Florida

Showing 40 of 145 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.